Literature DB >> 19115178

Withdrawal of life-sustaining therapies and brain death in the intensive care unit.

Panayiotis N Varelas1, Tamer Abdelhak, Lotfi Hacein-Bey.   

Abstract

The majority of patients who die in intensive care units (ICUs), do so as a result of the withdrawal of life-sustaining treatments or as a result of brain death. With the increasing shortage of transplantable organs, there is growing interest in both these patient populations and their potential for organ donation after cardiac death (DCD) or death by neurological criteria. Therefore, it is imperative for neurologists and neurosurgeons to be familiar with both processes when consulted to evaluate these very sick patients in the ICU. The medicolegal and ethical considerations, the factors that lead to the decision for withdrawal (with special attention to prognostication of the major neurological diseases encountered in an ICU), the process of withdrawal of life-sustaining treatment itself, and the DCD process will be examined. The medicolegal aspects of brain death will also be examined, with particular focus on the process and the various pitfalls and misconceptions.

Entities:  

Mesh:

Year:  2008        PMID: 19115178     DOI: 10.1055/s-0028-1105969

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  5 in total

1.  Current status and recent advances of liver transplantation from donation after cardiac death.

Authors:  M Thamara Pr Perera; Simon R Bramhall
Journal:  World J Gastrointest Surg       Date:  2011-11-27

2.  Integrating Palliative Care Into the Care of Neurocritically Ill Patients: A Report From the Improving Palliative Care in the ICU Project Advisory Board and the Center to Advance Palliative Care.

Authors:  Jennifer A Frontera; J Randall Curtis; Judith E Nelson; Margaret Campbell; Michelle Gabriel; Anne C Mosenthal; Colleen Mulkerin; Kathleen A Puntillo; Daniel E Ray; Rick Bassett; Renee D Boss; Dana R Lustbader; Karen J Brasel; Stefanie P Weiss; David E Weissman
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

3.  Factors associated with the withdrawal of life-sustaining therapies in patients with severe traumatic brain injury: a multicenter cohort study.

Authors:  Nicolas Côte; Alexis F Turgeon; François Lauzier; Lynne Moore; Damon C Scales; Francis Bernard; Ryan Zarychanski; Karen E A Burns; Maureen O Meade; David Zygun; Jean-François Simard; Amélie Boutin; Jacques G Brochu; Dean A Fergusson
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

4.  Withdrawal of technological life support following subarachnoid hemorrhage.

Authors:  Robert G Kowalski; Tiffany R Chang; J Ricardo Carhuapoma; Rafael J Tamargo; Neeraj S Naval
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

5.  Withdrawal of Life-Sustaining Treatment Mediates Mortality in Patients With Intracerebral Hemorrhage With Impaired Consciousness.

Authors:  Ayham Alkhachroum; Antonio J Bustillo; Negar Asdaghi; Erika Marulanda-Londono; Carolina M Gutierrez; Daniel Samano; Evie Sobczak; Dianne Foster; Mohan Kottapally; Amedeo Merenda; Sebastian Koch; Jose G Romano; Kristine O'Phelan; Jan Claassen; Ralph L Sacco; Tatjana Rundek
Journal:  Stroke       Date:  2021-09-29       Impact factor: 7.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.